Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

A benign helminth alters the host immune system and the gut microbiota in a rat model system

L. Wegener Parfrey, M. Jirků, R. Šíma, M. Jalovecká, B. Sak, K. Grigore, K. Jirků Pomajbíková,

. 2017 ; 12 (8) : e0182205. [pub] 20170803

Language English Country United States

Document type Journal Article

Helminths and bacteria are major players in the mammalian gut ecosystem and each influences the host immune system and health. Declines in helminth prevalence and bacterial diversity appear to play a role in the dramatic rise of immune mediated inflammatory diseases (IMIDs) in western populations. Helminths are potent modulators of immune system and their reintroduction is a promising therapeutic avenue for IMIDs. However, the introduction of helminths represents a disturbance for the host and it is important to understand the impact of helminth reintroduction on the host, including the immune system and gut microbiome. We tested the impact of a benign tapeworm, Hymenolepis diminuta, in a rat model system. We find that H. diminuta infection results in increased interleukin 10 gene expression in the beginning of the prepatent period, consistent with induction of a type 2 immune response. We also find induction of humoral immunity during the patent period, shown here by increased IgA in feces. Further, we see an immuno-modulatory effect in the small intestine and spleen in patent period, as measured by reductions in tissue immune cells. We observed shifts in microbiota community composition during the patent period (beta-diversity) in response to H. diminuta infection. However, these compositional changes appear to be minor; they occur within families and genera common to both treatment groups. There was no change in alpha diversity. Hymenolepis diminuta is a promising model for helminth therapy because it establishes long-term, stable colonization in rats and modulates the immune system without causing bacterial dysbiosis. These results suggest that the goal of engineering a therapeutic helminth that can safely manipulate the mammalian immune system without disrupting the rest of the gut ecosystem is in reach.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016446
003      
CZ-PrNML
005      
20180515103801.0
007      
ta
008      
180515s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0182205 $2 doi
035    __
$a (PubMed)28771620
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Wegener Parfrey, Laura $u Departments of Botany and Zoology, University of British Columbia, Vancouver, Canada. Integrated Microbial Biodiversity Program, Canadian Institute for Advanced Research, Toronto, Canada.
245    12
$a A benign helminth alters the host immune system and the gut microbiota in a rat model system / $c L. Wegener Parfrey, M. Jirků, R. Šíma, M. Jalovecká, B. Sak, K. Grigore, K. Jirků Pomajbíková,
520    9_
$a Helminths and bacteria are major players in the mammalian gut ecosystem and each influences the host immune system and health. Declines in helminth prevalence and bacterial diversity appear to play a role in the dramatic rise of immune mediated inflammatory diseases (IMIDs) in western populations. Helminths are potent modulators of immune system and their reintroduction is a promising therapeutic avenue for IMIDs. However, the introduction of helminths represents a disturbance for the host and it is important to understand the impact of helminth reintroduction on the host, including the immune system and gut microbiome. We tested the impact of a benign tapeworm, Hymenolepis diminuta, in a rat model system. We find that H. diminuta infection results in increased interleukin 10 gene expression in the beginning of the prepatent period, consistent with induction of a type 2 immune response. We also find induction of humoral immunity during the patent period, shown here by increased IgA in feces. Further, we see an immuno-modulatory effect in the small intestine and spleen in patent period, as measured by reductions in tissue immune cells. We observed shifts in microbiota community composition during the patent period (beta-diversity) in response to H. diminuta infection. However, these compositional changes appear to be minor; they occur within families and genera common to both treatment groups. There was no change in alpha diversity. Hymenolepis diminuta is a promising model for helminth therapy because it establishes long-term, stable colonization in rats and modulates the immune system without causing bacterial dysbiosis. These results suggest that the goal of engineering a therapeutic helminth that can safely manipulate the mammalian immune system without disrupting the rest of the gut ecosystem is in reach.
650    _2
$a zvířata $7 D000818
650    _2
$a Bacteria $x klasifikace $x izolace a purifikace $7 D001419
650    _2
$a biodiverzita $7 D044822
650    _2
$a feces $x chemie $7 D005243
650    _2
$a ženské pohlaví $7 D005260
650    12
$a střevní mikroflóra $7 D000069196
650    _2
$a regulace genové exprese $x imunologie $7 D005786
650    _2
$a interakce hostitele a parazita $x imunologie $7 D006790
650    _2
$a Hymenolepis diminuta $x imunologie $7 D048190
650    12
$a imunitní systém $7 D007107
650    _2
$a imunoglobulin A $x analýza $x imunologie $7 D007070
650    _2
$a interleukin-10 $x genetika $x metabolismus $7 D016753
650    _2
$a střeva $x mikrobiologie $x parazitologie $7 D007422
650    12
$a biologické modely $7 D008954
650    _2
$a fylogeneze $7 D010802
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a slezina $x imunologie $7 D013154
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jirků, Milan $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, České Budějovice, Czech Republic.
700    1_
$a Šíma, Radek $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, České Budějovice, Czech Republic.
700    1_
$a Jalovecká, Marie $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, České Budějovice, Czech Republic.
700    1_
$a Sak, Bohumil $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, České Budějovice, Czech Republic.
700    1_
$a Grigore, Karina $u Departments of Botany and Zoology, University of British Columbia, Vancouver, Canada.
700    1_
$a Jirků Pomajbíková, Kateřina $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, České Budějovice, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 12, č. 8 (2017), s. e0182205
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28771620 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180515103935 $b ABA008
999    __
$a ok $b bmc $g 1300070 $s 1013286
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 12 $c 8 $d e0182205 $e 20170803 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20180515

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...